Your browser doesn't support javascript.
loading
Characteristics of the Gut Microbiota in Regard to Atopic Dermatitis and Food Allergies of Children.
Nekrasova, Alexandra I; Kalashnikova, Irina G; Bobrova, Maria M; Korobeinikova, Anna V; Bakoev, Sirozhdin Yu; Ashniev, German A; Petryaikina, Ekaterina S; Nekrasov, Alexander S; Zagainova, Angelica V; Lukashina, Mariya V; Tolkacheva, Larisa R; Zhdanova, Anastasia S; Mukhin, Vladimir E; Yudin, Vladimir S; Keskinov, Anton A; Makarov, Valentin V; Kraevoy, Sergey A; Yudin, Sergey M.
Afiliación
  • Nekrasova AI; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency, Pogodinskaya Str. 10/1, 119121 Moscow, Russia.
  • Kalashnikova IG; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency, Pogodinskaya Str. 10/1, 119121 Moscow, Russia.
  • Bobrova MM; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency, Pogodinskaya Str. 10/1, 119121 Moscow, Russia.
  • Korobeinikova AV; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency, Pogodinskaya Str. 10/1, 119121 Moscow, Russia.
  • Bakoev SY; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency, Pogodinskaya Str. 10/1, 119121 Moscow, Russia.
  • Ashniev GA; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency, Pogodinskaya Str. 10/1, 119121 Moscow, Russia.
  • Petryaikina ES; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency, Pogodinskaya Str. 10/1, 119121 Moscow, Russia.
  • Nekrasov AS; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency, Pogodinskaya Str. 10/1, 119121 Moscow, Russia.
  • Zagainova AV; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency, Pogodinskaya Str. 10/1, 119121 Moscow, Russia.
  • Lukashina MV; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency, Pogodinskaya Str. 10/1, 119121 Moscow, Russia.
  • Tolkacheva LR; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency, Pogodinskaya Str. 10/1, 119121 Moscow, Russia.
  • Zhdanova AS; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency, Pogodinskaya Str. 10/1, 119121 Moscow, Russia.
  • Mukhin VE; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency, Pogodinskaya Str. 10/1, 119121 Moscow, Russia.
  • Yudin VS; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency, Pogodinskaya Str. 10/1, 119121 Moscow, Russia.
  • Keskinov AA; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency, Pogodinskaya Str. 10/1, 119121 Moscow, Russia.
  • Makarov VV; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency, Pogodinskaya Str. 10/1, 119121 Moscow, Russia.
  • Kraevoy SA; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency, Pogodinskaya Str. 10/1, 119121 Moscow, Russia.
  • Yudin SM; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical and Biological Agency, Pogodinskaya Str. 10/1, 119121 Moscow, Russia.
Biomedicines ; 12(3)2024 Mar 01.
Article en En | MEDLINE | ID: mdl-38540166
ABSTRACT
The gut microbiota plays an important role in maintaining human health, as well as in the development of various pathologies, as indicated by a large amount of research. One of the manifestations of an imbalance in the gut microbiome composition is the appearance of various diseases or immune reactions, in particular, atopic dermatitis (AD) and/or food allergies (FA). In this research, using 16S NGS sequencing, it was found that the gut microbiome of children with food allergies and children with atopic dermatitis can be characterized as having higher inflammatory potential. Both groups exhibited an abundance of representatives from the Pasteurellaceae and Erysipelotrichaceae families, as well as a decrease in the relative number of representatives from the Barnesiellaceae family compared to healthy participants. In the group of participants with food allergies, there was a decrease in the relative number of Desulfovibrionaceae representatives and Bifidobacteriaceae family enrichment in relatively healthy participants. In addition, when comparing this group with patients with atopic dermatitis, it was revealed that a number of representatives of such families as Erysipelotrichaceae, Ruminococcaceae and Sutterellaceae prevailed. This information confirms that AD and FA correlate with changes in the composition of the gut microbiota. Further research is needed to determine the cause-effect connections and the effect of compounds derived from the microbiota on the AD and FA development and progression, as well as to create new probiotic drugs to prevent and modulate immune responses, including at an early age.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_zoonosis Idioma: En Revista: Biomedicines Año: 2024 Tipo del documento: Article País de afiliación: Rusia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_zoonosis Idioma: En Revista: Biomedicines Año: 2024 Tipo del documento: Article País de afiliación: Rusia
...